]>
IRCT20141209020258N103 IRCT 2019-04-08 Arak University of Medical Sciences The role of N-acetyl Cysteine in the eradication of H.Pylori The role of N-acetyl Cysteine in the eradication of H.Pylori 2018-03-06 anticipated 167 Complete https://irct.ir/trial/38569 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple individual randomization with random number table in division of groups in two groups A and B. Randomization method: Simple randomization. Random unit: Individual. How to build sequences: First, we set the framework for our statistical society. We started from a table point in a row or column. Given the type of code in the row, we chose the same number of digits. After that, the numbers control the path. We noticed smaller numbers of the statistical community. We have to continue this work so that the number of samples is completed.Even numbers were used for intervention group and odd numbers were used for the control group. Allocation concealment:Numbered drug containers, Blinding description: This study is double blind. Researcher who complete questionnaire and analyzer are blind (double blind).Outcome assessor and analyzer don't aware from grouping.The person evaluating the outcome is unaware of the grouping. Groups A and B are available to analyzer and outcome assessor. 2-3 Dyspepsia. Intervention 1: Intervention group: We treat intervention group 4 drugs (Clarithromycin - Amoxicillin - Omeprazole - Bismuth)(Abidi Co) and N-Acetylcysteine (Ave Sina Co)600 milligram every 12 hours for 2 weeks. Intervention 2: Control group: We treat patients with regime of standard by 4 drugs (Clarithromycin - Amoxicillin - Omeprazole - Bismuth)(Abidi Co) in 2 weeks for first group. Yes - There is a plan to make this available What will be shared: When we publish article in journal When: After the article is published To whom: researcher in university Conditions: If there are additional questions Where to obtain: Dr Kheiri How to obtain: They have to write letters to the professors and the university Comments:
public Dr Zahedin Kheiri
Payambar Azam complex, Basij squre ,Sardasht
Arak Iran (Islamic Republic of) 3848176941 +98 86 3222 2003 z.kheiri@arakmu.ac.ir Arak University of Medical Sciences scientific Dr Zahedin Kheiri
Payambar Azam complex, Basij squre ,Sardasht
Arak Iran (Islamic Republic of) 3848176941 +98 86 3222 2003 z.kheiri@arakmu.ac.ir Arak University of Medical Sciences Iran (Islamic Republic of) Age over 20 years They have not already received the eradication regimen 20 years no limit Both Pregnancy and breastfeeding Nausea and vomiting Lack of cooperation K30 Functional dyspepsia Treatment - Drugs Treatment - Drugs Intervention group: We treat intervention group 4 drugs (Clarithromycin - Amoxicillin - Omeprazole - Bismuth)(Abidi Co) and N-Acetylcysteine (Ave Sina Co)600 milligram every 12 hours for 2 weeks. Control group: We treat patients with regime of standard by 4 drugs (Clarithromycin - Amoxicillin - Omeprazole - Bismuth)(Abidi Co) in 2 weeks for first group Eradication Helicobacter infection. Timepoint: 4 weeks after treatment. Method of measurement: Urease respiratory test. Arak University of Medical Sciences Approved 2018-02-26 Arak University Of Medical Sciences Research Center, Payambar Azam Complex, Basij Squre ,Sardasht,Arak Arak Markazi Iran (Islamic Republic of)